Trial Profile
Non-vitamin K Antagonist Oral Anticoagulants in patients with atrial high rate episodes - an investigator-driven, prospective, randomised, double-blind, multi-centre trial initiated by the European Society of Cardiology and AFNET
Status:
Discontinued
Phase of Trial:
Phase III/IV
Latest Information Update: 22 Feb 2024
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary) ; Aspirin
- Indications Embolism; Stroke
- Focus Therapeutic Use
- Acronyms NOAH
- 24 Jan 2024 This trial has been Completed in Germany, According to European Clinical Trials Database record.
- 13 Nov 2023 Results of subanalysis of assessing the efficacy and safety of anticoagulation in patients with AHRE lasting more than 24 hour, presented at the American Heart Association Scientific Sessions 2023
- 12 Nov 2023 Results published in the European Heart Journal